Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Adverse events after tiotropium 5.0 µg · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Long‐acting inhaled bronchodilators for cystic fibrosis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events Â · adults and children with cystic fibrosis

1 finding from 1 review

Short‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Very low

Adverse events Â · adults and children with cystic fibrosis

It is very uncertain whether short‐acting inhaled beta‐2 agonists changes adverse events Â compared with placebo (very low certainty).

1 finding from 1 review

Short‐acting inhaled bronchodilators for cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 47 participants
Very low